Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Kedrion (Italy)
h-index: 21
Total citations: 1,760
Total papers: 97
Homepage:
https://www.kedrion.com/
Recent papers from Kedrion (Italy)
Population Pharmacokinetics of Plasma‑Derived Factor X Using Clotting and Chromogenic Assays: A WAPPS‑Hemo Model
Haemophilia · 2026
Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency
Immunotherapy · 2026
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study)
Advances in Therapy · 2026
Continuous Observability of Human Biological Age through Ontological Binding of Molecular Diagnostics and Digital Physiology
2026
TCP-BioSync: A Unified Framework for Continuous Quantification of Biological Age through Ontological Binding of Molecular Diagnostics and Digital Physiology
2026
Almost Three Decades of Post-Marketing Experience With a Human Intravenous Immunoglobulin 5%: Analysis of a Propriety Pharmacovigilance Database
Current Therapeutic Research · 2026
Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population data
EBioMedicine · 2025
Ceruloplasmin administration in the preclinical mouse model of aceruloplasminemia reveals a sex-related variation in biodistribution
Communications Biology · 2025
Proof of concept of a new plasma complement Factor H from waste plasma fraction
Frontiers in Immunology · 2024
New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia
Communications Biology · 2024
New plasma protein C and protein S concentrate: A synergy for therapeutic purposes
Vox Sanguinis · 2023
Lipid dysmetabolism in ceruloplasmin‐deficient mice revealed both in vivo and ex vivo by MRI, MRS and NMR analyses
FEBS Open Bio · 2023
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment
Pharmaceutics · 2023
ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura
Thrombosis Update · 2022
Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
BMJ Open · 2022
Evaluation of prophylactic polyclonal anti‐D antibodies: Differences in Fc‐glycosylation in commercial products
Vox Sanguinis · 2021
Intra‐ and interassay variations of two thrombin generation methods
International Journal of Laboratory Hematology · 2021
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
International Journal of Molecular Sciences · 2021
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
Pharmaceuticals · 2020
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
Transfusion · 2020